The Top Companies operating in the Spain Tyrosine Hydroxylase Deficiency Market are typically global pharmaceutical and biotechnology firms specializing in rare diseases and orphan drug development. Given the monogenic nature of THD, the market is dominated by companies that produce or are actively developing the core symptomatic treatment (L-DOPA/carbidopa formulations) and, more...